Arnold Pharmaceuticals Sprints To Nasdaq

As a clinical-stage global biopharmaceutical company, Adlai Nortye has made new moves recently. The company submitted F-1 document to the US Securities and Exchange Commission, on July 27, 2023, asking to list on the Nasdaq under the symbol ANL.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.